PUBLIC CONTRACT · 2022
4180075/2022 - Aq. Central D559 - Darunavir 800 mg + cobic 150 mg+ emtricitabi 200 mg + tenofovir alaf 10 mg comp
- Contract value
- €89,007.24
- Signed on
- 25 January 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 8884272PUBLISHED SUBJECT
4180075/2022 - AQ. CENTRAL D559 - DARUNAVIR 800 MG + COBIC 150 MG+ EMTRICITABI 200 MG + TENOFOVIR ALAF 10 MG COMP
Parties involved
- Awardee
- - - JANSSEN CILAG FARMACEUTICA LDA
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - JANSSEN CILAG FARMACEUTICA LDA
Values and timeline
- Contract price
- €89,007.24
- Procedure base price
- €89,007.24
- Total effective price
- €89,007.24
- Publication date
- 9 February 2022
- Award date
- 25 January 2022
- Signing date
- 25 January 2022
- Performance period
- 5 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2019/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5780788
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.